ASA Submits Recommendations to FDA for International Rescheduling of Cannabis
This week, we submitted comments relating to the efficacy and medical usefulness of cannabis as a medical treatment. In early April, the Food and Drug Administration (FDA) issued a notice in the federal register asking for public comments on cannabis...
Read more